Citius Pharmaceuticals, Inc. Payments for Advance to Affiliate
Citius Pharmaceuticals, Inc. (CTXR) reported Payments for Advance to Affiliate of $1.33 million for the 12-month period ending 2025-09-30, per its 10-K filed 2025-12-23.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsForAdvanceToAffiliate · last filed 2025-12-23
- Citius Pharmaceuticals, Inc. payments for advance to affiliate for the quarter ending 2025-09-30 was $231.28K.
- Citius Pharmaceuticals, Inc. payments for advance to affiliate for the quarter ending 2025-06-30 was -$1.60M.
- Citius Pharmaceuticals, Inc. payments for advance to affiliate for the quarter ending 2025-03-31 was $0.00.
- Citius Pharmaceuticals, Inc. payments for advance to affiliate for the quarter ending 2024-12-31 was $2.70M.
- Citius Pharmaceuticals, Inc. payments for advance to affiliate for fiscal 2025 was $1.33M, a 50.69% decline from fiscal 2024.
- Citius Pharmaceuticals, Inc. payments for advance to affiliate for fiscal 2024 was $2.70M, a 65.09% decline from fiscal 2023.
- Citius Pharmaceuticals, Inc. payments for advance to affiliate for fiscal 2023 was $7.73M, a 187.52% increase from fiscal 2022.
- Citius Pharmaceuticals, Inc. payments for advance to affiliate for fiscal 2022 was $2.69M.
| Period end | Payments for Advance to Affiliate | Payments for Advance to Affiliate 3 month | Payments for Advance to Affiliate 6 month | Payments for Advance to Affiliate 9 month | Payments for Advance to Affiliate 12 month |
|---|---|---|---|---|---|
| 2025-09-30 | $231.28K derived: 10-K 12 month − 10-Q 9 month · filed 2025-12-23 | -$1.37M derived: sum of 2 quarters · filed 2025-12-23 | -$1.37M derived: sum of 3 quarters · filed 2025-12-23 | $1.33M 10-K · filed 2025-12-23 | |
| 2025-06-30 | -$1.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-08-12 | -$1.60M derived: sum of 2 quarters · filed 2025-08-12 | $1.10M 10-Q · filed 2025-08-12 | -$6.21M derived: sum of 4 quarters · filed 2025-12-23 | |
| 2025-03-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-05-14 | $2.70M 10-Q · filed 2025-05-14 | -$4.61M derived: sum of 3 quarters · filed 2025-12-23 | ||
| 2024-12-31 | $2.70M 10-Q · filed 2025-02-14 | -$4.61M derived: sum of 2 quarters · filed 2025-12-23 | |||
| 2024-09-30 | -$7.31M derived: 10-K 12 month − 10-Q 9 month · filed 2025-12-23 | $2.70M 10-K · filed 2025-12-23 | |||
| 2024-06-30 | $10.01M 10-Q · filed 2024-08-12 | ||||
| 2023-09-30 | $7.73M 10-Q · filed 2024-08-12 | $7.73M 10-K · filed 2024-12-27 | |||
| 2022-09-30 | $2.69M 10-K · filed 2023-12-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |